VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
17 hedge funds and large institutions have $1.74M invested in VIVEVE MED INC in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.
451% more capital invested
Capital invested by funds: $316K → $1.74M (+$1.43M)
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
89% more funds holding
Funds holding: 9 → 17 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$999K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$257K |
| 3 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$202K |
| 4 |
VF
Virtu Financial
New York
|
+$159K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$108K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$120K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
VIVE Hedge Fund Activity: Q1 2021 in Review
17 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q1 2021, worth a combined $1.74M — up 451% from $316K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new VIVE positions and 2 closed out — a net gain of 8 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, adding an estimated $999K. The largest seller was HRT Financial, exiting entirely with an estimated $120K sold.
- 17 institutional investors held VIVEVE MED INC (VIVE) as of Q1 2021, up from 9 in Q4 2020.
- Funds reported $1.74M of VIVEVE MED INC stock for Q1 2021, up 451% quarter-over-quarter.
- 10 funds opened new VIVEVE MED INC positions in Q1 2021 and 2 closed out, a net change of +8 holders.
- The largest VIVEVE MED INC buyer in Q1 2021 was BlackRock, an estimated $999K added.
- The largest VIVEVE MED INC seller in Q1 2021 was HRT Financial, an estimated $120K sold.
Based on aggregated 13F filings for Q1 2021.